HIV treatment in children: latest news

HIV treatment in children resources

  • HIV treatment

    HIV treatment is very effective in children with HIV, making it a long-term, manageable condition. In the UK, the standards of HIV treatment for children are set out...

    From: Booklets

    Information level Level 2
  • HIV & children

    This booklet provides information about treatment and care for children living with HIV. ...

    From: Booklets

    Information level Level 2
  • Children

    This factsheet provides some practical information that you might find useful if you are the parent or carer of an HIV-positive child.With the right treatment...

    From: Factsheets

    Information level Level 2
  • Treatment in children

    There is very good evidence that anti-HIV drugs can work well in babies and children, and there have been big falls in the amount of...

    From: Factsheets

    Information level Level 2
  • HIV treatment in children

    An outline of the issues surrounding anti-HIV therapy in children, highlighting the differences from adults in the course of HIV disease, the choice of medications,...

    From: HIV treatments directory

    Information level Level 4

HIV treatment in children features

HIV treatment in children news from aidsmap

More news

HIV treatment in children news selected from other sources

  • Kids Who Start HIV Treatment With Low CD4s Largely Regain Them

    HIV-positive children who have low CD4 counts when starting treatment by and large experience a rebound to normal levels of those immune cells. After two years on HIV meds, 92 percent of the children achieved a CD4 count of 500 or above. Just nine children (1 percent) experienced an AIDS-defining illness during treatment. Children starting with fewer than 200 CD4 cells/mm3 took 1.29 years to reach a CD4 count over 500 cells/mm3.

    07 April 2015 | AIDSMeds
  • Merck places children's HIV drug in shared non-profit patent pool

    U.S. drugmaker Merck & Co has contributed an HIV medicine for children to an international shared patent pool in a move that should speed the development of cheap pediatric formulations for use in poor countries.

    24 February 2015 | Reuters
  • Pneumonia risk far higher for HIV-positive children, study shows

    HIV-positive children in developing countries are six times more likely to die from pneumonia than children without the virus, research suggests. The first global study into pneumonia deaths in children with HIV has found that, in one year, pneumonia affected 1.4 million children and led to a further 88,000 deaths.

    07 January 2015 | Science Daily
  • UNITAID will invest to enable universal HIV care for children

    The UNITAID Executive Board finished its twenty-first meeting and decided that UNITAID will invest up to $63 million through the Elizabeth Glaser Pediatric AIDS Foundation to bring early infant diagnosis for HIV to the heart of communities in nine African countries. This will pave the way to universal access for testing and enable a ten-fold increase in treatment, thus transforming global childhood HIV/AIDS. Initiating treatment before the twelfth week of life reduces HIV-related mortality by 75%.

    17 December 2014 | UNITAID
  • PEPFAR’s ‘Global Pediatric ARV Commitment-To-Action’ Aims To Improve Drug Access

    Since the start of President Obama’s Administration, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has achieved a four-fold increase and is now providing 7.7 million people with life-saving antiretroviral (ARV) treatment worldwide. Despite this, only 1 in 4 of the 3.2 million children living with HIV/AIDS worldwide are today receiving treatment.

    09 December 2014 | US Department of State
  • The Medicines Patent Pool (MPP) Signs Licensing Agreement with AbbVie for HIV Paediatric Formulations of Lopinavir and Ritonavir

    he licence will enable other companies and organisations to re-formulate and manufacture specially designed LPV/r and r paediatric treatments for distribution in low- and middle-income countries where 99% of children with HIV in the developing world live.

    02 December 2014 | Medicines Patent Pool
  • NNRTI + 3 NRTIs may be strong first regimen in UK/Ireland children

    Children starting antiretroviral therapy (ART) with a nonnucleoside (NNRTI) plus 3 nucleosides (NRTIs) had the lowest 2-year virologic failure rate in a study of 997 children in the United Kingdom and Ireland. Five-year toxicity rates were similar with the NNRTI and protease inhibitor (PI) regimens studied.

    24 November 2014 | International AIDS Society
  • Ugandan activists fear ‘nonsensical’ HIV law increases infection of children

    Medical experts and HIV activists fear Uganda’s HIV and AIDS Prevention and Control Act is having the opposite effect and causing people to shy away from seeking treatment.

    26 October 2014 | Key Correspondents
  • Early HIV drugs are 'not a cure'

    Giving drugs within hours of HIV infection is not a cure for HIV, according to doctors treating a baby in Milan.

    03 October 2014 | BBC Health
  • Study Supports Earlier Initiation of HAART in HIV-Infected Children

    New research supports early initiation of highly active antiretroviral therapy (HAART) in children with HIV infection.

    03 October 2014 | Medscape (requires registration)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also